These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10691514)

  • 1. Canadian biomedical collaboration keeps on growing.
    Spurgeon D
    Nature; 2000 Jan; 403(6768):350. PubMed ID: 10691514
    [No Abstract]   [Full Text] [Related]  

  • 2. The Medical Research Council of Canada: integrating research to Canada's health care system.
    Friesen HG
    Nat Med; 1998 Dec; 4(12):1353-5. PubMed ID: 9846564
    [No Abstract]   [Full Text] [Related]  

  • 3. Outlook: finding improved medicines: the role of academic-industrial collaboration.
    Chin-Dusting J; Mizrahi J; Jennings G; Fitzgerald D
    Nat Rev Drug Discov; 2005 Nov; 4(11):891-7. PubMed ID: 16247439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomedical research and the pharmaceutical industry.
    Rosenfield G
    Pharos Alpha Omega Alpha Honor Med Soc; 1996; 59(3):46. PubMed ID: 9074323
    [No Abstract]   [Full Text] [Related]  

  • 5. The NIH, research institutions and industry: working together on a shared goal.
    Omary MB
    Gastroenterology; 2007 May; 132(5):1647-50. PubMed ID: 17484859
    [No Abstract]   [Full Text] [Related]  

  • 6. [Relationship between research and health policy: a Canadian perspective. A research program of the National Health Service].
    Berrino F
    Epidemiol Prev; 1998; 22(2):67-9. PubMed ID: 9789374
    [No Abstract]   [Full Text] [Related]  

  • 7. [New developments also in general medicine. GSK relies on research as well as transparent collaboration with physicians (interview by Dirk Einecke, Wolfgang van den Bergh, Peter Overbeck and Cornelius Heyer)].
    Marshall CG; Strohmeyer T
    MMW Fortschr Med; 2011 May; 153(21):10-1. PubMed ID: 21739676
    [No Abstract]   [Full Text] [Related]  

  • 8. Academia-industry collaboration: an integral element for building "omic" resources.
    Hill DE; Brasch MA; del Campo AA; Doucette-Stamm L; Garrels JI; Glaven J; Hartley JL; Hudson JR; Moore T; Vidal M
    Genome Res; 2004 Oct; 14(10B):2010-4. PubMed ID: 15489319
    [No Abstract]   [Full Text] [Related]  

  • 9. HSFC/CCS pharmaceutical roundtable: a model of contribution of industry to cardiovascular research. Heart and Stroke Foundation of Canada. Canadian Cardiovascular Society.
    Dagenais GR
    Can J Cardiol; 1994 Sep; 10(7):699-701. PubMed ID: 7922824
    [No Abstract]   [Full Text] [Related]  

  • 10. Contributions of Canadian research to medicine. Address of welcome.
    Genest J
    Can Med Assoc J; 1970 Oct; 103(8):818-21. PubMed ID: 5476312
    [No Abstract]   [Full Text] [Related]  

  • 11. Canadian Society for Clinical Investigation representation to the Eastman Commission: research and development in the pharmaceutical industry--a Sisyphyian tale.
    MacLeod SM
    Clin Invest Med; 1986; 9(2):133-6. PubMed ID: 3731578
    [No Abstract]   [Full Text] [Related]  

  • 12. Building bridges between academia and industry: forms; foundations; functions.
    Bander KW; Rosenberg LE
    Yale J Biol Med; 1997; 70(3):213-7. PubMed ID: 9544491
    [No Abstract]   [Full Text] [Related]  

  • 13. Canadian drug companies fund universities.
    Spurgeon D
    Nature; 1993 Jun; 363(6429):484. PubMed ID: 8505969
    [No Abstract]   [Full Text] [Related]  

  • 14. Dundee: discovering life sciences.
    Tasker H
    Drug Discov Today; 2006 May; 11(9-10):379-82. PubMed ID: 16635798
    [No Abstract]   [Full Text] [Related]  

  • 15. Glasgow and the West of Scotland region--bioscience buds beginning to bloom.
    O'Neill MF
    Drug Discov Today; 2006 May; 11(9-10):387-90. PubMed ID: 16635800
    [No Abstract]   [Full Text] [Related]  

  • 16. The interface between publicly funded and industry-funded research in pediatric psychopharmacology: opportunities for integration and collaboration.
    Vitiello B; Heiligenstein JH; Riddle MA; Greenhill LL; Fegert JM
    Biol Psychiatry; 2004 Jul; 56(1):3-9. PubMed ID: 15219466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National Health Research and Development Program.
    Can Ment Health; 1976 Jun; 24(2):33-5. PubMed ID: 1022366
    [No Abstract]   [Full Text] [Related]  

  • 18. Conflict of interest or productive collaboration? The pharma: academic relationship and its implications for headache medicine.
    Finkel AG
    Headache; 2006; 46(7):1181-5. PubMed ID: 16866722
    [No Abstract]   [Full Text] [Related]  

  • 19. Health care reform in motion. Canadian RNs see promise despite problems.
    Fuller C
    Revolution (Oakl); 2004; 5(5):6-7. PubMed ID: 15575100
    [No Abstract]   [Full Text] [Related]  

  • 20. Canadian budget. Most initiatives stalled; health research grows.
    Kondro W
    Science; 2001 Dec; 294(5551):2452-3. PubMed ID: 11752546
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.